Shares of VCA Inc. (NASDAQ:WOOF) reached a new 52-week high during trading on Friday . The stock traded as high as $68.40 and last traded at $68.33, with a volume of 250,091 shares changing hands. The stock had previously closed at $66.42.

WOOF has been the topic of several research analyst reports. CL King initiated coverage on shares of VCA in a research note on Friday, April 1st. They set a “buy” rating on the stock. Stifel Nicolaus raised their price objective on shares of VCA from $68.00 to $75.00 and gave the company a “buy” rating in a research note on Thursday, April 28th. Finally, Jefferies Group assumed coverage on shares of VCA in a research note on Wednesday, June 8th. They issued a “hold” rating on the stock. One analyst has rated the stock with a hold rating and six have issued a buy rating to the stock. The stock currently has an average rating of “Buy” and an average target price of $64.50.

The firm has a market cap of $5.53 billion and a PE ratio of 25.60. The stock’s 50-day moving average price is $65.78 and its 200 day moving average price is $58.00.

VCA (NASDAQ:WOOF) last issued its earnings results on Wednesday, April 27th. The company reported $0.66 EPS for the quarter, beating the consensus estimate of $0.61 by $0.05. During the same quarter in the previous year, the firm posted $0.50 earnings per share. The firm earned $563.40 million during the quarter, compared to analyst estimates of $556.03 million. VCA’s quarterly revenue was up 12.8% compared to the same quarter last year. Equities analysts predict that VCA Inc. will post $2.87 EPS for the current year.

In other news, VP Neil Tauber sold 50,000 shares of the business’s stock in a transaction that occurred on Tuesday, May 24th. The shares were sold at an average price of $64.24, for a total value of $3,212,000.00. Following the completion of the transaction, the vice president now directly owns 174,161 shares in the company, valued at approximately $11,188,102.64. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, COO Arthur J. Antin sold 200,000 shares of the business’s stock in a transaction that occurred on Wednesday, May 18th. The shares were sold at an average price of $64.04, for a total transaction of $12,808,000.00. Following the completion of the transaction, the chief operating officer now owns 70,870 shares of the company’s stock, valued at $4,538,514.80. The disclosure for this sale can be found here.

Several institutional investors have recently modified their holdings of the stock. CG Asset Management LLC boosted its position in shares of VCA by 2.6% in the fourth quarter. CG Asset Management LLC now owns 25,340 shares of the company’s stock valued at $1,394,000 after buying an additional 650 shares during the last quarter. American Capital Management Inc. boosted its position in shares of VCA by 3.5% in the fourth quarter. American Capital Management Inc. now owns 20,800 shares of the company’s stock valued at $1,144,000 after buying an additional 700 shares during the last quarter. Retirement Systems of Alabama boosted its position in shares of VCA by 0.7% in the fourth quarter. Retirement Systems of Alabama now owns 103,621 shares of the company’s stock valued at $5,699,000 after buying an additional 703 shares during the last quarter. California State Teachers Retirement System boosted its position in shares of VCA by 1.6% in the fourth quarter. California State Teachers Retirement System now owns 152,494 shares of the company’s stock valued at $8,387,000 after buying an additional 2,363 shares during the last quarter. Finally, US Bancorp DE boosted its position in shares of VCA by 16.6% in the fourth quarter. US Bancorp DE now owns 30,684 shares of the company’s stock valued at $1,687,000 after buying an additional 4,369 shares during the last quarter.

VCA Inc is a national animal healthcare company operating in the United States and Canada. The Company operates in two segments: animal hospital and laboratory. The Company provides veterinary services and diagnostic testing to support veterinary care and also sells diagnostic imaging equipment and other medical technology products and related services to the veterinary market.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.